David Low
Stock Analyst at UBS
(2.95)
# 2,671
Out of 4,516 analysts
293
Total ratings
48.5%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Maintained: Hold | $106.00 | $123.18 | -13.95% | 21 | Jul 15, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Hold | $8.00 → $7.00 | $6.11 | +14.66% | 14 | Jul 8, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $35.60 → $34.25 | $31.90 | +7.37% | 16 | Jul 6, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $158.00 | $122.73 | +28.74% | 28 | Jul 1, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $19.60 | $21.66 | -9.51% | 32 | Jul 1, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 | $42.75 | +0.36% | 20 | May 28, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $28.31 | - | 24 | Apr 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $15.63 | +5.57% | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $1.02 | +28.08% | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $46.31 → $43.91 | $22.70 | +93.42% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4.00 → $3.90 | $3.26 | +19.63% | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $2.14 | +58.88% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.39 | +58.16% | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $192.09 | +56.18% | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $198.57 | +56.12% | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | 39.88 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.30 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.06 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $21.47 | n/a | 1 | Dec 4, 2019 |
Cochlear Limited
Jul 15, 2026
Maintained: Hold
Price Target: $106.00
Current: $123.18
Upside: -13.95%
Regis Healthcare Limited
Jul 8, 2026
Maintained: Hold
Price Target: $8.00 → $7.00
Current: $6.11
Upside: +14.66%
Ansell Limited
Jul 6, 2026
Maintained: Hold
Price Target: $35.60 → $34.25
Current: $31.90
Upside: +7.37%
CSL Limited
Jul 1, 2026
Maintained: Buy
Price Target: $158.00
Current: $122.73
Upside: +28.74%
Sonic Healthcare Limited
Jul 1, 2026
Maintained: Hold
Price Target: $19.60
Current: $21.66
Upside: -9.51%
Ramsay Health Care Limited
May 28, 2026
Maintained: Hold
Price Target: $42.90
Current: $42.75
Upside: +0.36%
ResMed Inc.
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $28.31
Upside: -
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $15.63
Upside: +5.57%
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $1.02
Upside: +28.08%
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $46.31 → $43.91
Current: $22.70
Upside: +93.42%
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $3.26
Upside: +19.63%
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $2.14
Upside: +58.88%
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.39
Upside: +58.16%
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $192.09
Upside: +56.18%
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $198.57
Upside: +56.12%
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: 39.88
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.30
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $15.06
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $21.47
Upside: n/a